Anavex Life Sciences Corp. (AVXL) Market Cap & Valuation Ratios
Anavex Life Sciences Corp. (AVXL) has a market cap of $123.3M, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
AVXLAnavex Life Sciences Corp.Follow AVXL — free
—
Price chart with a free account
- Market cap
- 123.3M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 23 Nov, in 30 days
Peers
biotechnology · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| AVXL | 0.1 | — | — | — | — | — | — | — |
| CHRS | 0.2 | — | 1.7 | — | — | +61% | -312% | — |
| MDWD | 0.2 | — | 12.6 | — | — | -40% | -268% | -126% |
| UPB | 0.2 | — | — | — | — | +16% | — | -61% |
| RNA | 0.1 | — | — | — | — | — | — | — |
| CDXS | 0.1 | — | 1.6 | — | -8.7% | +36% | -36% | -48% |
| CMPX | 0.1 | — | — | — | — | — | — | -81% |
| NKTX | 0.1 | — | — | — | — | — | — | -50% |
| HUMA | 0.1 | — | 36.5 | — | — | +159% | — | — |
| VYGR | 0.1 | — | — | — | — | -19% | -340% | -74% |
| LENZ | 0.1 | — | 3.5 | — | — | — | — | -75% |
| Median of these 10 | — | 3.5 | — | -8.7% | +26% | -290% | -74% |
.
Growth vs. price
each dot a company · hover or tap for valuesAnavex Life Sciences Corp. — questions
- What is Anavex Life Sciences Corp.'s market cap?
- $123.3M.
Every figure on this page comes from Anavex Life Sciences Corp.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.